ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
39 900,01
0,08%
DAX
18 704,42
-0,11%
Brent Oil
83,365
0,19%
Bitcoin
67 236,24
3,05%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Amicus Therapeutics Inc (FOLD)

  7. Amicus Therapeutics Inc (FOLD) Actualités

FOLD

Amicus Therapeutics (FOLD)

Amicus Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FOLD
DateHeureSourceTitreSymboleSociété
09/05/202422h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FOLDAmicus Therapeutics Inc
09/05/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FOLDAmicus Therapeutics Inc
09/05/202413h00GlobeNewswire Inc.Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
08/05/202413h00GlobeNewswire Inc.Amicus Therapeutics to Present at the Bank of America 2024 Health Care ConferenceNASDAQ:FOLDAmicus Therapeutics Inc
01/05/202413h00GlobeNewswire Inc.Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024NASDAQ:FOLDAmicus Therapeutics Inc
20/03/202412h00GlobeNewswire Inc.Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) ReportNASDAQ:FOLDAmicus Therapeutics Inc
11/03/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
05/03/202422h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
01/03/202413h00GlobeNewswire Inc.Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024NASDAQ:FOLDAmicus Therapeutics Inc
28/02/202413h00GlobeNewswire Inc.Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
15/02/202413h00GlobeNewswire Inc.Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024NASDAQ:FOLDAmicus Therapeutics Inc
14/02/202422h38Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:FOLDAmicus Therapeutics Inc
08/02/202413h00GlobeNewswire Inc.Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™NASDAQ:FOLDAmicus Therapeutics Inc
01/02/202413h00GlobeNewswire Inc.Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024NASDAQ:FOLDAmicus Therapeutics Inc
07/01/202422h00GlobeNewswire Inc.Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic OutlookNASDAQ:FOLDAmicus Therapeutics Inc
03/01/202413h00GlobeNewswire Inc.Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:FOLDAmicus Therapeutics Inc
05/12/202312h00GlobeNewswire Inc.Amicus Therapeutics Congratulates Executive Chairman John F. Crowley on Appointment as Next President and CEO of BIONASDAQ:FOLDAmicus Therapeutics Inc
08/11/202323h25Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:FOLDAmicus Therapeutics Inc
08/11/202313h00GlobeNewswire Inc.Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:FOLDAmicus Therapeutics Inc
01/11/202312h00GlobeNewswire Inc.Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023NASDAQ:FOLDAmicus Therapeutics Inc
27/10/202313h00GlobeNewswire Inc.Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023NASDAQ:FOLDAmicus Therapeutics Inc
16/10/202322h56Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:FOLDAmicus Therapeutics Inc
03/10/202313h00GlobeNewswire Inc.Amicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023NASDAQ:FOLDAmicus Therapeutics Inc
02/10/202314h20GlobeNewswire Inc.Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing CollaborationNASDAQ:FOLDAmicus Therapeutics Inc
02/10/202302h30PR Newswire (US)WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe DiseaseNASDAQ:FOLDAmicus Therapeutics Inc
28/09/202317h31Dow Jones NewsAmicus Therapeutics Gets FDA Approval for Pombiliti + OpfoldaNASDAQ:FOLDAmicus Therapeutics Inc
28/09/202316h41GlobeNewswire Inc.Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe DiseaseNASDAQ:FOLDAmicus Therapeutics Inc
01/09/202313h00GlobeNewswire Inc.Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023NASDAQ:FOLDAmicus Therapeutics Inc
29/08/202313h00GlobeNewswire Inc.Amicus Therapeutics Announces Presentation and Posters at the SSIEM Annual Symposium 2023NASDAQ:FOLDAmicus Therapeutics Inc
23/08/202323h46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FOLDAmicus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FOLD

Dernières Valeurs Consultées

LSE
CSCG
Capital Shopping Centres
COIN
ZAPUST
ZAP TOKEN
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés